Cargando…

CSACI position statement: epinephrine auto-injectors and children < 15 kg

Epinephrine (adrenaline) is the treatment of choice for anaphylaxis. While other medications, including H(1)-antihistamines, H(2)-antihistamines, corticosteroids, and inhaled beta-2 agonists are often used to treat anaphylaxis in the emergency setting, none of these medications has been shown to rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halbrich, Michelle, Mack, Douglas P., Carr, Stuart, Watson, Wade, Kim, Harold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485331/ https://www.ncbi.nlm.nih.gov/pubmed/26131015 http://dx.doi.org/10.1186/s13223-015-0086-9

Ejemplares similares

CSACI position statement: transition recommendations on existing epinephrine autoinjectors
por: Li, Lucy Dong Xuan, et al.
Publicado: (2021)

Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone
por: Kim, Laura, et al.
Publicado: (2014)

CSACI Position statement on the testing of food-specific IgG
por: Carr, Stuart, et al.
Publicado: (2012)

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
por: Quirt, J., et al.
Publicado: (2018)

Unintentional injection to the bone with a pediatric epinephrine auto-injector
por: Ibrahim, Mariam, et al.
Publicado: (2018)

Epinephrine auto-injector needle length: The impact of winter clothing
por: Dreborg, Sten, et al.
Publicado: (2020)

Global disparities in availability of epinephrine auto-injectors
por: Tanno, Luciana Kase, et al.
Publicado: (2023)

CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults
por: Segal, Audrey O, et al.
Publicado: (2013)

CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma
por: Issa-El-Khoury, Karine, et al.
Publicado: (2015)

Update on the usage and safety of epinephrine auto-injectors, 2017
por: Posner, Larry S, et al.
Publicado: (2017)

Do epinephrine auto-injectors have an unsuitable needle length for young children?
por: Kim, Laura, et al.
Publicado: (2014)

What factors affect the carriage of epinephrine auto-injectors by teenagers?
por: Macadam, Clare, et al.
Publicado: (2012)

Pediatric Epinephrine Auto-injector Accident Without Digital Ischemia
por: Shapiro, Alex L, et al.
Publicado: (2019)

Effectiveness of epinephrine auto‐injector skill training for school nurses
por: Shiraishi, Yuko, et al.
Publicado: (2019)

Unintentional Epinephrine Auto-Injector Maxillofacial Injury in a Pediatric Patient
por: David, Jason, et al.
Publicado: (2022)

Epinephrine auto-injector prescriptions to food-allergic patients in primary care in The Netherlands
por: Saleh-Langenberg, Jacquelien, et al.
Publicado: (2015)

Epinephrine Auto-Injectors for Anaphylaxis Treatment in the School Setting: A Discussion Paper
por: Tarr Cooke, Abigail, et al.
Publicado: (2019)

Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy
por: Tsai, Gina, et al.
Publicado: (2014)

Ability to successfully use an epinephrine auto-injector after switching to a different device
por: Boyle, Robert, et al.
Publicado: (2015)

Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea
por: Cho, Hyunseok, et al.
Publicado: (2019)

Underprescription of epinephrine auto-injectors in food-allergic patients at high risk for anaphylaxis in primary care
por: Saleh-Langenberg, Jacquelien, et al.
Publicado: (2015)

Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?
por: Dreborg, Sten, et al.
Publicado: (2016)

International recommendations on epinephrine auto-injector doses often differ from standard weight-based guidance: a review and clinical proposals
por: Dreborg, Sten, et al.
Publicado: (2022)

Erratum to: Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?
por: Dreborg, Sten, et al.
Publicado: (2017)

Hooked epinephrine auto-injector devices in children: four case reports with three different proposed mechanisms
por: Goldman, Ran D., et al.
Publicado: (2020)

Early introduction is not enough: CSACI statement on the importance of ongoing regular ingestion as a means of food allergy prevention
por: Abrams, Elissa M., et al.
Publicado: (2023)

Epinephrine auto injector administration by parents or patients for anaphylaxis during supervised oral food challenges and assessment of confidence
por: Baerg, Ingrid, et al.
Publicado: (2014)

The burden of treatment and compliance with the epinephrine auto-injector (EAI) in food allergic patients of all ages: a pilot study
por: Kemna, Jozephina C, et al.
Publicado: (2011)

Letter to the editor for the article "Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy"
por: Song, T Ted
Publicado: (2014)

Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI)
por: Leith, Eric, et al.
Publicado: (2006)

Prescribing of adrenaline auto-injectors
por: Kahlon, Gurnaaz Kaur
Publicado: (2015)

Management of anaphylaxis in schools: Evaluation of an epinephrine auto-injector (EpiPen®) use by school personnel and comparison of two approaches of soliciting participation
por: Nguyen Luu, Nha Uyen, et al.
Publicado: (2012)

Training and administration of epinephrine auto-injectors for anaphylaxis treatment in US schools: results from the EpiPen4Schools(®) pilot survey
por: Hogue, Susan L, et al.
Publicado: (2016)

Epinephrine delivery via EpiPen(®) Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances
por: Worm, Margitta, et al.
Publicado: (2020)

Epinephrine Auto-Injector Prescription and Use: A Retrospective Analysis and Clinical Risk Assessment of Adult Patients Sensitized to Lipid Transfer Protein
por: Urbani, Sara, et al.
Publicado: (2022)

CSACI position statement: Newer generation H(1)-antihistamines are safer than first-generation H(1)-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria
por: Fein, Michael N., et al.
Publicado: (2019)

Prescribing adrenaline auto-injectors in Slovenian children
por: Vesel, Tina, et al.
Publicado: (2015)

Mistaking an Auto-injector for a Ballpoint Pen
por: Maeda, Atsuo, et al.
Publicado: (2020)

Auto-injection accidentelle d’épinéphrine par un bambin
por: Edgerley, Sarah, et al.
Publicado: (2021)

Comparison of the robustness and functionality of three adrenaline auto-injectors
por: Schwirtz, Andreas, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ip7hmfe720i1gmdnbcr5cq29bd